Mozart Therapeutics Raises $25 Million in Expanded Series A Financing to Support Clinical Development of First-in-Class CD8 Treg Modulators for the Treatment of Autoimmune Diseases

Funding supports clinical development of first therapeutic candidate and pipeline expansion Marie-Claire Peakman, PhD, Partner, Pfizer Ventures, and Jasmina Marjanovic, PhD, Director AbbVie Ventures, to join Mozart’s Board of Directors SEATTLE, June 7, 2023 /PRNewswire/ — Mozart Therapeutics, a leading developer of CD8 Treg Modulators for the treatment of autoimmune and inflammatory diseases, today announced … Read more